Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers.
Oncogene. 2021 Apr;40(14):2496-2508. doi: 10.1038/s41388-021-01710-y. Epub 2021 Mar 5.
Oncogene. 2021.
PMID: 33674744
Free PMC article.
RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers.
Alblihy A, Alabdullah ML, Toss MS, Algethami M, Mongan NP, Rakha EA, Madhusudan S.
Alblihy A, et al. Among authors: alabdullah ml.
Mol Biomed. 2020 Dec 30;1(1):19. doi: 10.1186/s43556-020-00023-y.
Mol Biomed. 2020.
PMID: 35006434
Free PMC article.
Item in Clipboard
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers.
Alblihy A, Alabdullah ML, Ali R, Algethami M, Toss MS, Mongan NP, Rakha EA, Madhusudan S.
Alblihy A, et al. Among authors: alabdullah ml.
Biomedicines. 2021 Jan 8;9(1):56. doi: 10.3390/biomedicines9010056.
Biomedicines. 2021.
PMID: 33435622
Free PMC article.
Item in Clipboard
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
Alabdullah ML, Ahmad DA, Moseley P, Madhusudan S, Chan S, Rakha E.
Alabdullah ML, et al.
J Obstet Gynaecol. 2019 May;39(4):522-528. doi: 10.1080/01443615.2018.1534091. Epub 2019 Feb 4.
J Obstet Gynaecol. 2019.
PMID: 30712414
Item in Clipboard
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.
Ahmad DA, Negm OH, Alabdullah ML, Mirza S, Hamed MR, Band V, Green AR, Ellis IO, Rakha EA.
Ahmad DA, et al. Among authors: alabdullah ml.
Breast Cancer Res Treat. 2016 Oct;159(3):457-67. doi: 10.1007/s10549-016-3967-9. Epub 2016 Sep 3.
Breast Cancer Res Treat. 2016.
PMID: 27592113
Free PMC article.
Item in Clipboard
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
Jerjees DA, Negm OH, Alabdullah ML, Mirza S, Alkaabi M, Hameed MR, Abduljabbar R, Muftah A, Nolan CC, Green AR, Tighe PJ, Band V, Ellis IO, Rakha EA.
Jerjees DA, et al. Among authors: alabdullah ml.
Breast Cancer Res Treat. 2015 Feb;150(1):91-103. doi: 10.1007/s10549-015-3308-4. Epub 2015 Feb 21.
Breast Cancer Res Treat. 2015.
PMID: 25701120
Item in Clipboard
Cite
Cite